![]() |
Large Medium Small |
SHANGHAI - New China Life, the Chinese joint venture of Swiss insurer Zurich
|
New China Life was initially planning to submit its IPO application to the Hong Kong stock exchange in March and if everything goes smoothly it may be able to complete the dual-listing in July, it said.
The Chinese insurer has appointed UBS
New China Life was not immediately available for comment.
Apart from Zurich, Central Huijin Investment Co, the domestic investment arm of China's sovereign wealth fund as well as top steel company Baosteel also own a stake in New China Life.